Vaccines, Vaccination, and Immunology for Avian Influenza Viruses in Poultry

Avian Influenza

Volumn , Issue , 2009, Pages 407-451

  Swayne, David E ^a   Kapczynski, Darrell R ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antigen recognition and processing; Embryonating chicken eggs (ECE); Immune stimulating complexes (ISCOMS); Inactivated whole AI virus vaccines; Mucosal immunity; Pathogen associated molecular patterns (PAMPs); T cell activation cytokines; Toll like receptor (TLR) family

Indexed keywords

EID: 84889996890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813818634.ch19     Document Type: Chapter

References (283)

1. Abraham, A., V. Sivanandan, D. Karunakaran, D.A. Halvorson, and J.A. Newman. 1988. Comparative serological evaluation of avian influenza vaccine in turkeys. Avian Diseases 32: 659-662.
2. Ada, G.L., and P.D. Jones. 1986. The immune response to influenza infection. Current Topics in Microbiology and Immunology 128: 1-54.
3. Albini, B., G. Wick, E. Rose, and E. Orlans. 1974. Immunoglobulin production in chicken Harderian glands. International Archives of Allergy and Immunology 47(1): 23-34.
4. Alexander, D.J., and G. Parsons. 1980. Protection of chickens against challenge with virulent influenza A viruses of Hav5 subtype conferred by prior infection with influenza A viruses of Hsw1 subtype. Archives of Virology 66: 265-269.
5. Allan, W.H., C.R. Madeley, and A.P. Kendal. 1971. Studies with avian influenza A viruses: cross protection experiments in chickens. Journal of General Virology 12: 79-84.
6. Allison, A.C., and N.E. Byars. 1992. Syntex adjuvant formulation. Research in Immunology 143(5): 519-525.
7. Altstein, A.D., A.K. Gitelman, Y.A. Smirnov, L.M. Piskareva, L.G. Zakharova, G.V. Pashvykina, M.M. Shmarov, O.P. Zhirnov, N.P. Varich, P.O. Ilyinskii, and A.M. Shneider. 2006. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Archives of Virology 151(5): 921-931.
8. Anderson, R.W., J.R. Bennink, J.W. Yewdell, W.L. Maloy, and J.E. Coligan. 1992. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Molecular Immunology 29(9): 1089-1096.
9. Andrew, M.E., B.E. Coupar, G.L. Ada, and D.B. Boyle. 1986. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microbial Pathogenesis 1(5): 443-452.
10. Aucouturier, J., L. Dupuis, and V. Ganne. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine 19(17-19): 2666-2672.
11. Bang, B.G., and F.B. Bang. 1968. Localized lymphoid tissues and plasma cells in paraocular and paranasal organ systems in chickens. American Journal of Pathology 53(5): 735-751.
12. Barun, K., M.W. Shaw, P.A. Rota, M.W. Harmon, J.J. Esposito, R. Rott, N.J. Cox, A.P. Kendal, and K. De-Barun. 1988. Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. Vaccine 6: 257-261.
13. Beard, C.W. 1981. Immunization approaches to avian influenza. In: R.W. Bankowski (ed.). Proceedings of the First International Symposium on Avian Influenza, April 1981, Beltsville, Maryland. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 172-177.
14. Beard, C.W. 1981. Turkey influenza vaccination [letter]. Veterinary Record 108: 545.
15. Beard, C.W. 1987. To vaccinate or not to vaccinate. In: B.C. Easterday and C.W. Beard (eds.). Proceedings of the Second International Symposium on Avian Influenza, Georgia Center for Continuing Education, the University of Georgia, Athens, Georgia, USA, September 3-5, 1986. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 258-263.
16. Beard, C.W. 1992. The role of vaccines and vaccination. In: B.C. Easterday (ed.). Proceedings of the Third International Symposium on Avian Influenza, May 27-29, 1992, Madison, Wisconsin. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 409-420.
17. Beard, C.W., and B.C. Easterday. 1973. ATurkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus. Avian Diseases 17: 173-181.
18. Beard, C.W., W.M. Schnitzlein, and D.N. Tripathy. 1991. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Diseases 35: 356-359.
19. Beard, C.W., W.M. Schnitzlein, and D.N. Tripathy. 1992. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Diseases 36: 1052-1055.
20. Beato, M.S., M. Rigoni, A. Milani, and I. Capua. 2007. Generation of avian influenza reassortant viruses of the H7N5 subtype as potential vaccine candidates to be used in the framework of a "DIVA" vaccination strategy. Avian Dis 51(1 Suppl.): 479-480.
21. Beato, M.S., A. Toffan, R. De Nardi, A. Cristalli, C. Terregino, G. Cattoli, and I. Capua. 2007. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 25(20): 4064-4072.
22. Beaudette, F.R., C.B. Hudson, and A.H. Saxe. 1932. An outbreak of fowl plague in New Jersey in 1929. Journal of Agriculture Research 49: 83-92.
23. Beck, I., H. Gerlach, E. Burkhardt, and E.F. Kaleta. 2003. Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3. Vaccine 21(9-10): 1006-1022.
24. Bertelsen, M.F., J. Klausen, E. Holm, C. Grondahl, and P.H. Jorgensen. 2007. Serological response to vaccination against avian influenza in zoobirds using an inactivated H5N9 vaccine. Vaccine 25(22): 4345-4349.
25. Bienenstock, J., A.D. Befus, M. McDermott, S. Mirski, K. Rosenthal, and A. Tagliabue. 1983. The mucosal immunological network: compartmentalization of lymphocytes, natural killer cells, and mast cells. Annals of the New York Academy of Sciences 409: 164-170.
26. Bouma, A., T. Tiensin, I. Claassen, M. Nielen, M. van Boven, and J.A. Stegeman. 2007. Estimation of the critical proportion of chickens in a flock to be immunized to prevent major outbreaks of HPAI H5N1. Abstracts of OIE/FAO conference on vaccination: a tool for the control of avian influenza 20-22 March 2007, Verona, Italy, p. 60.
27. Bourlet, Y., G. Behar, F. Guillemot, N. Frechin, A. Billault, A.M. Chausse, R. Zoorob, and C. Auffray. 1988. Isolation of chicken major histocompatibility complex class II (B-L) b chain sequences: comparison with mammalian b chains and expression in lymphoid organs. EMBO Journal 7(4): 1031-1039.
28. Bowie, A.G., and I.R. Haga. 2005. The role of Toll-like receptors in the host response to viruses. Molecular Immunology 42(8): 859-867.
29. Boyle, D.B., and B.E.H. Coupar. 1988. Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Research 10: 343-356.
30. Boyle, D.B., P. Selleck, and H.G. Heine. 2000. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Australian Veterinary Journal 78(1): 44-48.
31. Brown, D.W., Y. Kawaoka, R.G. Webster, and H.L. Robinson. 1992. Assessment of retrovirusexpressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. Avian Diseases 36: 515-520.
32. Brugh, M., C.W. Beard, and H.D. Stone. 1979. Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. American Journal of Veterinary Research 40: 165-169.
33. Brugh, M., and H.D. Stone. 1987. Immunization of chickens against influenza with hemagglutininspecific (H5) oil emulsion vaccine. In: B.C. Easterday and C.W. Beard (eds.). Proceedings of the Second International Symposium on Avian Influenza, Georgia Center for Continuing Education, the University of Georgia, Athens, Georgia, USA, September 3-5, 1986. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 283-292.
34. Bublot, M., F.X. Le Gros, D. Nieddu, N. Pritchard, T.R. Mickle, and D.E. Swayne. 2007. Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand. Avian Diseases 51: 332-337.
35. Bublot, M., N. Pritchard, J.S. Cruz, T.R. Mickle, P. Selleck, and D.E. Swayne. 2007. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Diseases 51: 498-500.
36. Bublot, M., N. Pritchard, D.E. Swayne, P. Selleck, K. Karaca, D.L. Suarez, J.C. Audonnet, and T.R. Mickle. 2006. Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences 1081: 193-201.
37. Bublot, M., D.E. Swayne, P. Selleck, E. Montiel, N. Pritchard, M. Lee, and T.R. Mickle. 2006. TROVAC AI H5, an avian influenza fowlpox vector vaccine, as an alternative vaccine for hatcheries. Developments in Biologicals 124: 248-249.
38. Burns, R.B. 1982. Histology and immunology of Peyer's patches in the domestic fowl (Gallus domesticus). Research in Veterinary Science 32(3): 359-367.
39. Butterfield, W.K., and C.H. Campbell. 1978. Vaccination for fowl plague. American Journal of Veterinary Research 39(4): 671-674.
40. Calderon, H.M.L., V.H. Rodriguez, L.D. Garcia, M.R. Palacios, R.T. Nickle, N.E.H. Montiel, G. Tinoco, and G.J. Garcia. 2007. Interference of passive immunity with the efficiency of a recombining vaccine on the first day of life to prevent bird flu. In: Proceedings of the XXII ANECA Annual Congress, pp. 245-252.
41. Capua, I., S. Marangon, P. Dalla, and U. Santucci. 2000. Vaccination for avian influenza in Italy. Veterinary Record 147(26): 751.
42. Capua, I., and D.J. Alexander. 2004. Avian influenza: recent developments. Avian Pathology 33: 393-404.
43. Capua, I., G. Cattoli, and S. Marangon. 2004. DIVA-a vaccination strategy enabling the detection of field exposure to avian influenza. Developments in Biologicals 119: 229-233.
44. Capua, I., and S. Marangon. 2003. The use of vaccination as an option for the control of avian influenza. Avian Pathology 32(4): 335-343.
45. Capua, I., and S. Marangon. 2003. Vaccination policy applied for the control of avian influenza in Italy. Developments in Biologicals 114: 213-219.
46. Capua, I., and S. Marangon. 2007. Control and prevention of avian influenza in an evolving scenario. Vaccine 25(30): 5645-5652.
47. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, and J.F. Rodriguez. 2003. Development of a DIVA (differentiating infected from vaccinated animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathology 32(1): 47-55.
48. Capua, I., C. Terregino, G. Cattoli, and A. Toffan. 2004. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 lowpathogenicity avian influenza virus. Avian Pathology 33(2): 158-163.
49. Capua, I., and D.J. Alexander. 2006. The challenge of avian influenza to the veterinary community. Avian Pathology 35(3): 189-205.
50. Capua, I., and S. Marangon. 2004. Vaccination for avian influenza in Asia. Vaccine 22(31-32): 4137-4138.
51. Capua, I., and S. Marangon. 2006. Control of avian influenza in poultry. Emerging Infectious Diseases 12(9): 1319-1324.
52. Cardona, C.J., B.R. Charlton, and P.R. Woolcock. 2006. Persistence of immunity in commercial egg-laying hens following vaccination with a killed H6N2 avian influenza vaccine. Avian Diseases 50(3): 374-379.
53. Cattoli, G., A. Milani, F. Bettini, B.M. Serena, M. Mancin, C. Terregino, and I. Capua. 2006. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "DIVA" vaccination strategy for avian influenza infections in poultry. Avian Pathology 35(2): 154-159.
54. Cattoli, G., C. Terregino, V. Brasola, J.F. Rodriguez, and I. Capua. 2003. Development and preliminary validation of an ad hoc N1-N3 discriminatory test for the control of avian influenza in Italy. Avian Diseases 47: 1060-1062.
55. Cauthen, A.N., D.E. Swayne, M.J. Sekellick, P.I. Marcus, and D.L. Suarez. 2007. Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. Journal of Virology 81(4): 1838-1847.
56. Chambers, T.M., Y. Kawaoka, and R.G. Webster. 1988. Protection of chickens from lethal influenza infection by vaccine-expressed hemagglutinin. Virology 167: 414-421.
57. Chen, H., Y. Matsuoka, D. Swayne, Q. Chen, N.J. Cox, B.R. Murphy, and K. Subbarao. 2003. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine 21: 4430-4436.
58. Chen, S., L. Sun, W. Liu, X. Sun, and X. Liu. 2006. Recombinant fowlpox virus coexpressing HA and NA gene from subtype H5N1 of avian influenza virus and its protective efficacy. Weishengwu Xuebao 46(1): 111-114.
59. Cherbonnel, M., J. Rousset, and V. Jestin. 2003. Strategies to improve protection against lowpathogenicity H7 avian influenza virus infection using DNA vaccines. Avian Diseases 47: 1181-1186.
60. Claassen, I.J.T.M., E.J. Jahja, A. Sahesti, A. Farida, F. Balk, and A. Bouma. 2007. PD50 experiments demonstrate that avian influenza vaccines used in Indonesia differ greatly in protective capacity. Abstracts of OIE/FAO Conference on Vaccination: A Tool for the Control of Avian Influenza OIE/FAO, Verona, Italy, p. 73.
61. Clancy, R., and J. Bienenstock. 1974. The proliferative response of bronchus-associated lymphoid tissue after local and systemic immunization. Journal of Immunology 112(6): 1997-2001.
62. Clancy, R., A. Cripps, K. Murree-Allen, S. Yeung, and M. Engel. 1985. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 2(8469-8470): 1395-1397.
63. Cole, K., S.L. Layton, M.M. Cox, Y.M. Kwon, W.J. Berghman, W.J. Bottje, and B.M. Hargis. Development and primary evaluation of a recombinant salmonella expressing M2e and CD154 as a vaccine vector for avian influenza. In: Abstracts of the FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy, p. 54.
64. Couch, R.B., and J.A. Kasel. 1983. Immunity to influenza in man. Annual Review of Microbiology 37: 529-549.
65. Cox, J.C., and A.R. Coulter. 1997. Adjuvants-a classification and review of their modes of action. Vaccine 15(3): 248-256.
66. Crawford, J., B. Wilkinson, A. Vosnesensky, G. Smith, M. Garcia, H. Stone, and M.L. Perdue. 1999. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17: 2265-2274.
67. Crawford, J.M., M. Garcia, H. Stone, D. Swayne, R. Slemons, and M.L. Perdue. 1998. Molecular characterization of the hemagglutinin gene and oral immunization with a waterfowl-origin avian influenza virus. Avian Diseases 42(3): 486-496.
68. Czifra, G., and U. Carlsson. 2007. Vaccination of zoo birds in Sweden 2006. In: Abstracts of the FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy, p. 67.
69. Das, A.M., E. Spackman, C. Thomas, D.E. Swayne, and D.L. Suarez. 2007. Detection of H5N1 high pathogenicity avian influenza virus in meat and tracheal samples from experimentally infected chickens. Avian Diseases, in press.
70. Davies, I.A. 1986. Immunological adjuvants of natural origin and their adverse effects. Adverse Drug Reactions and Acute Poisoning Reviews 5(1): 1-21.
71. Davison, S., R.J. Eckroade, and A.F. Ziegler. 2003. A review of the 1996-1998 nonpathogenic H7N2 avian influenza outbreak in Pennsylvania. Avian Diseases 47(Suppl.): 823-827.
72. Davison, S., A.F. Ziegler, and R.J. Eckroade. 1998. Comparison of an antigen-capture enzyme immunoassay with virus isolation for avian influenza from field samples. Avian Diseases 42(4): 791-795.
73. De, B.K., M.W. Shaw, P.A. Rota, M.W. Harmon, J.J. Esposito, R. Rott, N.J. Cox, and A.P. Kendal. 1988. Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. Vaccine 6: 257-261.
74. Desheva, J.A., X.H. Lu, A.R. Rekstin, L.G. Rudenko, D.E. Swayne, N.J. Cox, J.M. Katz, and A.I. Klimov. 2006. Characterization of an influenza A H5N2 reassortant as a candidate for liveattenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine 24(47-48): 6859-6866.
75. Di Trani, L., P. Cordioli, E. Falcone, G. Lombardi, A. Moreno, G. Sala, and M. Tollis. 2003. Standardization of an inactivated H7N1 avian influenza vaccine and efficacy against A/chicken/Italy/13474/99 high-pathogenicity virus infection. Avian Diseases 47: 1042-1046.
76. Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and C.R.E. Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663): 1529-1531.
77. Donahoe, J.P. 1998. Inactivated avian influenza whole virus vaccines. In: D.E. Swayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 228-236.
78. Donovan, B.W., J.D. Reuter, Z. Cao, A. Myc, K.J. Johnson, and J.R. Baker, Jr. 2000. Prevention of murine influenza A virus pneumonitis by surfactant nano-emulsions. Antiviral Chemistry & Chemotherapy 11(1): 41-49.
79. Easterday, B.C., and K. Van Reeth. 1999. Swine influenza. In: B.E. Straw, S. D'Allaire, W.L. Mengeling, and D.J. Taylor (eds.). Diseases of Swine. Iowa State University Press: Ames, IA, pp. 277-290.
80. Ellis, T.M., C.W. Leung, M.K. Chow, L.A. Bissett, W. Wong, Y. Guan, and J.S.M. Peiris. 2004. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathology 33(4): 405-412.
81. Eskelund, K.H. 1984. Use of inactivated vaccine to control avian influenza outbreaks. Proceedings of the Western Poultry Disease Conference 33: 8-10.
82. Fatunmbi, O.O., J.A. Newman, V. Sivanandan, and D.A. Halvorson. 1992. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine 10: 623-626.
83. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272(5258): 50-53.
84. Folitse, R., D.A. Halvorson, and V. Sivanandan. 1998. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens. Avian Diseases 42(1): 173-178.
85. Frame, D.D., B.J. McCluskey, R.E. Buckner, and F.D. Halls. 1996. Results of an H7N3 avian influenza vaccination program in commercial meat turkeys. Proceedings of the Western Poultry Disease Conference 45: 32.
86. Fynan, E.F., H.L. Robinson, and R.G. Webster. 1993. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA and Cell Biology 12: 785-789.
87. Fynan, E.F., R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro, and H.L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proceedings of the National Academy of Sciences U S A 90: 11478-11482.
88. Gall-Recule, G., M. Cherbonnel, N. Pelotte, P. Blanchard, Y. Morin, and V. Jestin. 2007. Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Avian Diseases 51(1 SUPPL.): 490-494.
89. Gao, W., A.C. Soloff, X. Lu, A. Montecalvo, D.C. Nguyen, Y. Matsuoka, P.D. Robbins, D.E. Swayne, R.O. Donis, J.M. Katz, S.M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. Journal of Virology 80(4): 1959-1964.
90. Garcia, A., H. Johnson, D.K. Srivastava, D.A. Jayawardene, D.R. Wehr, and R.G. Webster. 1998. Efficacy of inactivated H5N2 influenza vaccines against lethal A/chicken/Queretaro/19/95 infection. Avian Diseases 42: 248-256.
91. Garcia-Garcia, J., H. Rodriguez, and H. Hernandez. Experimental studies and field trials with recombinant fowlpox vaccine in broilers in Mexico. In: D.E. Swayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 245-252.
92. Ge, J., G. Deng, Z. Wen, G. Tian, Y. Wang, J. Shi, X. Wang, Y. Li, S. Hu, Y. Jiang, C. Yang, K. Yu, Z. Bu, and H. Chen. 2007. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of Virology 81(1): 150-158.
93. Glenn, G.M., T. Scharton-Kersten, R. Vassell, G.R. Matyas, and C.R. Alving. 1999. Transcutaneous immunization with bacterial ADPribosylating exotoxins as antigens and adjuvants. Infection and Immunity 67(3): 1100-1106.
94. Gough, R.E., W.H. Allan, D.J. Knight, and J.W. Lieper. 1975. Further studies on the adjuvant effect of an interferon inducer (BRL 5907) on Newcastle disease and avian influenza inactivated vaccines. Research in Veterinary Science 19: 185-188.
95. Gradon, J.D., and L.I. Lutwick. 1999. Maintaining and enhancing vaccine immunogenicity. Infectious Disease Clinics of North America 13(1): 39-60, vi.
96. Halvorson, D.A. 1998. Epidemiology and control of avian influenza in Minnesota. In: Proceedings of the 47th New England Poultry Health Conference, New England Poultry Association: Portsmouth, New Hampshire, 5-11.
97. Halvorson, D.A. 1998. Strengths and weaknesses of vaccines as a control tool. In: D.E. Swayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 223-227.
98. Halvorson, D.A. 2002. The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine. Avian Pathology 31(1): 5-12.
99. Halvorson, D.A. 2002. Twenty-five years of avian influenza in Minnesota. In: Proceedings of the 53rd North Central Avian Disease Conference, NCADC: Minneapolis, 65-69.
100. He, H., K.J. Genovese, D.J. Nisbet, and M.H. Kogut. 2006. Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes. Molecular Immunology 43(7): 783-789.
101. He, Q., A. Mitchell, T. Morcol, and S.J. Bell. 2002. Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clinical and Diagnostic Laboratory Immunology 9(5): 1021-1024.
102. Hilton, L.S., A.G.D. Bean, and J.W. Lowenthal. 2002. The emerging role of avian cytokines as immunotherapeutics and vaccine adjuvants. Veterinary Immunology and Immunopathology 85(3-4): 119-128.
103. Holmgren, J. 1991. Mucosal immunity and vaccination. FEMS Microbiology and Immunology 4(1): 1-9.
104. Holt, P.S., H.D. Stone, R.W. Moore, and R.K. Gast. 2005. Development of a lavage procedure to collect lung secretions from chickens for evaluating respiratory humoral immunity. Avian Pathology 34(5): 396-398.
105. Hu, K.F., K. Lovgren-Bengtsson, and B. Morein. 2001. Immunostimulating complexes (ISCOMs) for nasal vaccination. Advanced Drug Delivery Reviews 51(1-3): 149-159.
106. Hunt, L.A., D.W. Brown, H.L. Robinson, C.W. Naeve, and R.G. Webster. 1988. Retrovirusexpressed hemagglutinin protects against lethal influenza virus infections. Journal of Virology 62: 3014-3019.
107. Illum, L., I. Jabbal-Gill, M. Hinchcliffe, A.N. Fisher, and S.S. Davis. 2001. Chitosan as a novel nasal delivery system for vaccines. Advanced Drug Delivery Reviews 51(1-3): 81-96.
108. Janeway, C.A., Jr., B. Jones, and A. Hayday. 1998. Specificity and function of T cells bearing gamma delta receptors. Immunology Today 9(3): 73-76.
109. Jeurissen, S.H., E.M. Janse, P.R. Lehrbach, E.E. Haddad, A. Avakian, and C.E. Whitfill. 1998. The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease. Immunology 95(3): 494-500.
110. Jia, L., X. Liu, Y. Zhang, D. Peng, and R. Zhang. 2004. Protective efficacy of recombinant fowl pox virus-HA vaccine against H5 subtype of avian influenzavirus in domestic geese. Chinese Journal of Veterinary Science 24: 417-419.
111. Jia, L., D. Peng, Y. Zhang, H. Liu, and X. Liu. 2003. Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus. Weishengwu Xuebao 43(6): 722-727.
112. Kaiser, P., T.Y. Poh, L. Rothwell, S. Avery, S. Balu, U.S. Pathania, S. Hughes, M. Goodchild, S. Morrell, M. Watson, N. Bumstead, J. Kaufman, and J.R. Young. 2005. A genomic analysis of chicken cytokines and chemokines. Journal of Interferon and Cytokine Research 25(8): 467-484.
113. Kapczynski, D.R. 2006. Sequence analysis of the toll-like receptor 7 from gallinaceous and nongallinaceous species. In: G.C. Perry (ed.). Poultry Science Symposium Series, 28th ed. Carfax Publishing Company: Oxfordshire, p. 405.
114. Karaca, K., D.E. Swayne, D. Grosenbaugh, M. Bublot, A. Robles, E. Spackman, and R. Nordgren. 2005. Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats. Clinical and Diagnostic Laboratory Immunology 12(11): 1340-1342.
115. Karunakaran, D., J.A. Newman, D.A. Halvorson, and A. Abraham. 1987. Evaluation of inactivated influenza vaccines in market turkeys. Avian Diseases 31: 498-503.
116. King, D.J. 1991. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Diseases 35: 505-514.
117. Kodihalli, S., J.R. Haynes, H.L. Robinson, and R.G. Webster. 1997. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. Journal of Virology 71(5): 3391-3396.
118. Kodihalli, S., D.L. Kobasa, and R.G. Webster. 2000. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 18(23): 2592-2599.
119. Kodihalli, S., V. Sivanandan, K.V. Nagaraja, S.M. Goyal, and D.A. Halvorson. 1993. Antigencapture enzyme-immunoassay for detection of avian influenza-virus in turkeys. American Journal of Veterinary Research 54: 1385-1390.
120. Kodihalli, S., V. Sivanandan, K.V. Nagaraja, D. Shaw, and D.A. Halvorson. 1994. A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection. Vaccine 12: 1467-1472.
121. Kogut, M.H., M. Iqbal, H. He, V. Philbin, P. Kaiser, and A. Smith. 2005. Expression and function of Toll-like receptors in chicken heterophils. Developmental and Comparative Immunology 29(9): 791-807.
122. Krishnamurthy, S., Z.H. Huang, and S.K. Samal. 2000. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278(1): 168-182.
123. Kumar, M., H.J. Chu, J. Rodenberg, S. Krauss, and R.G. Webster. 2007. Association of serologic and protective responses of avian infuenza vaccines in chickens. Avian Diseases 51: 481-483.
124. Lamb, R.A., and R.M. Krug. 1996. Orthomyxoviridae: the viruses and their replication. In: B.N. Field, D.M. Knipe, and P.M. Howley (eds.). Fields Virology. Lippincott-Raven: New York, pp. 1353-1395.
125. Lee, C.W., D.A. Senne, and D.L. Suarez. 2004. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. Journal of Virology 78(15): 8372-8381.
126. Lee, C.W., D.A. Senne, and D.L. Suarez. 2004. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA. Vaccine 22(23-24): 3175-3181.
127. Lee, C.W., and D.L. Suarez. 2004. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. Journal of Virological Methods 119(2): 151-158.
128. Lee, C.W., and D.L. Suarez. 2005. Avian influenza virus: prospects for prevention and control by vaccination. Animal Health Research Reviews 6(1): 1-15.
129. Lee, C., D.A. Senne, and D.L. Suarez. 2004. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22(23-24): 3175-3181.
130. Lee, Y.J., H.W. Sung, J.G. Choi, E.K. Lee, O.M. Jeong, Y.K. Kwon, J.H. Kwon, C.S. Song, and J.H. Kim. 2007. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza. Avian Diseases 51: 476-478.
131. Lillehoj, H.S., X. Ding, R.A. Dalloul, T. Sato, A. Yasuda, and E.P. Lillehoj. 2005. Embryo vaccination against Eimeria tenella and E. acervulina infections using recombinant proteins and cytokine adjuvants. Journal of Parasitology 91(3): 666-673.
132. Lim, O.J., and Maheswaran. 1977. Purification and identification of turkey immunoglobulin-A. Avian Diseases 21: 675-696.
133. Liu, M., J.M. Wood, T. Ellis, S. Krauss, P. Seiler, C. Johnson, E. Hoffmann, J. Humberd, D. Hulse, Y. Zhang, R.G. Webster, and D.R. Perez. 2003. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314(2): 580-590.
134. Lozano, B., E. Soto, D. Sarfati, F. Castro, M. Gay, and A. Antillon. 2007. A novel engineered live viral vaccine against Newcastle disease and avian influenza subtype H5. In: Abstracts of the FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy, p. 50.
135. Lu, X., L.E. Edwards, J.A. Desheva, D.C. Nguyen, A. Rekstin, I. Stephenson, K. Szretter, N.J. Cox, L.G. Rudenko, A. Klimov, and J.M. Katz. 2006. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine 24(44-46): 6588-6593.
136. Lucio, E., D. Rodriguez, A. Morales, J. Chapa, and P. Munoz. 2007. Mucosal protection afforded by a killed spray avian influenza vaccine. In: Abstracts of the FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy, p. 66.
137. Lund, J.M., L. Alexopoulou, A. Sato, M. Karow, N.C. Adams, N.W. Gale, A. Iwasaki, and R.A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proceedings of the National Academy of Sciences U S A 101(15): 5598-5603.
138. Luschow, D., O. Werner, T.C. Mettenleiter, and W. Fuchs. 2001. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19(30): 4249-4259.
139. Maas, R.A., M.P.M. de Winter, S. Venema, H.L. Oei, and I.J.T.M. Claassen. 2000. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Veterinary Quarterly 22(4): 223-227.
140. MacDonald, M.R.W., A.L. Smith, and K.E. Magor. 2006. The toll-like receptor 7 (TLR7) genomic locus in ducks. In: 9th Avian Immunology Research Group Meeting, Paris, France, p. 19.
141. Marangon, S., L. Busani, and I. Capua. 2007. Practicalities of the implementation of a vaccination campaign for avian influenza. Avian Diseases 51: 297-303.
142. Marangon, S., I. Capua, G. Pozza, and U. Santucci. 2004. Field experiences in the control of avian influenza outbreaks in densely populated poultry areas. Developments in Biologicals 119: 155-164.
143. Martin, V., A. Forman, and J. Lubroth. 2006. Preparing for Highly Pathogenic Avian Influenza. FAO: Rome, pp. 1-62.
144. Martinet, W., X. Saelens, T. Deroo, S. Neirynck, R. Contreras, J.W. Min, and W. Fiers. 1997. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. European Journal of Biochemistry 247(1): 332-338.
145. Matsuoka, Y., H. Chen, N. Cox, K. Subbarao, J. Beck, and D. E. Swayne. 2003. Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza. Avian Diseases 47: 926-930.
146. McCapes, R.H., and R.A. Bankowski. 1987. Use of avian influenza vaccines in California turkey breeders. In: B.C. Easterday and C.W. Beard (eds.). Proceedings of the Second International Symposium on Avian Influenza, Georgia Center for Continuing Education, the University of Georgia, Athens, Georgia, USA, September 3-5, 1986. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 271-278.
147. McDermott, M.R., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. Journal of Immunology 122(5): 1892-1898.
148. Mcghee, J.R., J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10(2): 75-88.
149. McNulty, M.S., G.M. Allan, and B.M. Adair. 1986. Efficacy of avian influenza neuraminidasespecific vaccines in chickens. Avian Pathology 15: 107-115.
150. Medina, E., and C.A. Guzman. 2000. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunology and Medical Microbiology 27(4): 305-311.
151. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response. Current Opinions in Immunology 9(1): 4-9.
152. Medzhitov, R., and C.A. Janeway, Jr. 1998. An ancient system of host defense. Current Opinions in Immunology 10(1): 12-15.
153. Middleton, D., J. Bingham, P. Selleck, S. Lowther, L. Gleeson, P. Lehrbach, S. Robinson, J. Rodenberg, M. Kumar, and M. Andrew. 2007. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359(1): 66-71.
154. Mingxiao, M., J. Ningyi, W. Zhenguo, W. Ruilin, F. Dongliang, Z. Min, Y. Gefen, L. Chang, J. Leili, J. Kuoshi, and Z. Yingjiu. 2006. Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 24(20): 4304-4311.
155. Moriya, O. 1983. Ontogeny of lymphocytes expressing J chain in chickens. Cellular Immunology 80(1): 78-83.
156. Muir, W.I., W.L. Bryden, and A.J. Husband. 2000. Immunity, vaccination and the avian intestinal tract. Developmental and Comparative Immunology 24(2-3): 325-342.
157. Myers, T.J., and A.P. Morgan. 1998. Policy and guidance for licensure of avian influenza vaccines in the United States. In: D.E. Swayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 373-378.
158. Naeem, K. 1998. The avian influenza H7N3 outbreak in South Central Asia. In: D.E. Swayne and R.D. Slemons (eds.). Proceedings of the Fourth International Symposium on Avian Influenza, May 29-31, 1997, Athens, Georgia. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 31-35.
159. Naeem, K., and N. Siddique. Use of strategic vaccination for the control of avian influenza in Pakistan. Developments in biologicals 124: 145-150.
160. Nakaya, T., J. Cros, M.S. Park, Y. Nakaya, H.Y. Zheng, A. Sagrera, E. Villar, A. Garcia-Sastre, and P. Palese. 2001. Recombinant Newcastle disease virus as a vaccine vector. Journal of Virology 75(23): 11868-11873.
161. Narayan, O., B.T. Rouse, and G. Lang. 1970. A new influenza A virus infection in turkey. VI. Artificial immunization against the malignant virus strain turkey-Ontario 7732-66. Canadian Journal of Comparative Medicine and Veterinary Sciences 34: 72-79.
162. Nicholson, K.G., A.E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma, and M.C. Zambon. 2001. Safety and antigenicity of nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357(9272): 1937-1943.
163. O'Hagan, D.T., G.S. Ott, and G. Van Nest. 1997. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Molecular Medicine Today 3(2): 69-75.
164. Office Internationale des Epizooties. 2007. Avian influenza. Terrestrial Animal Health Code. Article 2.7.12.1. Available at http://www.oie.int/eng/normes/mcode/en_chapitre_2.7.12.htm. Office Internationale des Epizooties: Paris, France. Accessed April 24, 2007.
165. Office Internationale des Epizooties. 2007. Avian influenza vaccine manufacturers. http://www.oie.int/eng/AVIAN_INFLUENZA/AI_vaccines.pdf. Office Internationale des Epizooties: Paris, France. Accessed May 25, 2007.
166. Olah, I., and B. Glick. 1979. Structure of the germinal centers in the chicken caecal tonsil: light and electron microscopic and autoradiographic studies. Poultry Science 58(1): 195-210.
167. Olah, I., B. Glick, and R.L. Taylor, Jr. 1984. Meckel's diverticulum. II. A novel lymphoepithelial organ in the chicken. Anatomical Record 208(2): 253-263.
168. Park, M., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. 2006. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proceedings of the National Academy of Sciences U S A 103(21): 8203-8208.
169. Pasare, C., and R. Medzhitov. 2004. Tolldependent control mechanisms of CD4 T cell activation. Immunity 21(5): 733-741.
170. Payne, L.M., and P.C. Powell. 1984. The lymphoid system. In: B.M. Freeman (ed.). Physiology and Biochemistry of the Domestic Fowl. Academic Press: Orlando, FL, p. 278.
171. Peeters, B.P., O.S. de Leeuw, G. Koch, and A.L. Gielkens. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. Journal of Virology 73(6): 5001-5009.
172. Philbin, V.J., M. Iqbal, Y. Boyd, M.J. Goodchild, R.K. Beal, N. Bumstead, J. Young, and A.L. Smith. 2005. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens. Immunology 114(4): 507-521.
173. Philippa, J., C. Baas, W. Beyer, T. Bestebroer, R. Fouchier, D. Smith, W. Schaftenaar, and A. Osterhaus. 2007. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 25(19): 3800-3808.
174. Philippa, J.D., V.J. Munster, H. Bolhuis, T.M. Bestebroer, W. Schaftenaar, W.E. Beyer, R.A. Fouchier, T. Kuiken, and A.D. Osterhaus. 2005. Highly pathogenic avian influenza (H7N7): vaccination of zoo birds and transmission to nonpoultry species. Vaccine 23(50): 5743-5750.
175. Porter, R.E., Jr., and P.S. Holt. 1992. Use of a pilocarpine-based lavage procedure to study secretory immunoglobulin concentration in the alimentary tract of White Leghorn chickens. Avian Diseases 36(3): 529-536.
176. Prel, A., G. Gall-Recule, M. Cherbonnel, B. Grasland, M. Amelot, and V. Jestin. 2007. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 lowpathogenicity avian influenza virus challenge in Muscovy ducks. Avian Diseases 51(1 SUPPL.): 484-489.
177. Price, R.J. 1981. Commercial avian influenza vaccines. In: R.W. Bankowski (ed.). Proceedings of the First International Symposium on Avian Influenza, April 1981, Beltsville, Maryland. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 178-179.
178. Purchase, H.S. 1930. Active immunisation of fowls against fowl plague. Journal of Comparitive Pathology and Therapeutics 43: 151-157.
179. Qiao, C., K. Yu, Y. Jiang, C. Li, G. Tian, X. Wang, and H. Chen. Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza. Developments in Biologicals 124: 127-132.
180. Qiao, C.L., K.Z. Yu, Y.P. Jiang, Y.Q. Jia, G.B. Tian, M. Liu, G.H. Deng, X.R. Wang, Q.W. Meng, and X.Y. Tang. 2003. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathology 32(1): 25-31.
181. Qiao, C., Y. Jiang, K. Yu, G. Tian, and H. Chen. 2004 Immune efficacy of a recombinant fowlpox virus co-expressing HA and NA genes of avian influenza virus in SPF chickens. Scientia Agricultura Sinica 37: 605-608.
182. Quere, P., and F. Girard. 1999. Systemic adjuvant effect of cholera toxin in the chicken. Veterinary Immunology and Immunopathology 70(1-2): 135-141.
183. Ratcliffe, M.J., O. Lassila, J. Reynolds, J.R. Pink, and O. Vainio. 1987. A re-evaluation of the function of the bursa of Fabricius. Progress in Clinical and Biological Research 238: 3-14.
184. Reise Sousa, C. 2004. Toll-like receptors and dendritic cells: for whom the bug tolls. Seminars in Immunology 16(1): 27-34.
185. Renegar, K.B., and P.A.J. Small. 1991. Immunoglobulin A mediation of murine nasal antiinfluenza virus immunity. Journal of Virology 65: 2146-2148.
186. Renegar, K.B., and P.A.J. Small. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. Journal of Immunology 146: 1972-1978.
187. Rimmelzwaan, G.F., E.C. Claas, G. van Amerongen, J.C. de Jong, and A.D. Osterhaus. 1999. ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine 17(11-12): 1355-1358.
188. Robinson, H.L., L.A. Hunt, and R.G. Webster. 1993 Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11: 957-960.
189. Roth, J.A. 1999. Mechanistic bases for adverse vaccine reactions and vaccine failures. Advances in Veterinary Medicine 41: 681-700.
190. Roth, J.A., and A.R. Spickler. 2003. A survey of vaccines produced for OIE list A diseases in OIE member countries. Development in Biologicals 114: 5-25.
191. Rott, R., H. Becht, and M. Orlich. 1974. The significance of influenza virus neuraminidase in immunity. Journal of General Virology 22: 35-41.
192. Saelens, X., P. Vanlandschoot, W. Martinet, M. Maras, S. Neirynck, R. Contreras, W. Fiers, and W.M. Jou. 1999. Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. European Journal of Biochemistry 260(1): 166-175.
193. Sambhara, S., A. Kurichh, R. Miranda, T. Tumpey, T. Rowe, M. Renshaw, R. Arpino, A. Tamane, A. Kandil, O. James, B. Underdown, M. Klein, J. Katz, and D. Burt. 2001. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cellular Immunology 211(2): 143-153.
194. Savill, N.J., S.G. St Rose, M.J. Keeling, and E.J. Woolhouse Mark. 2007. Silent spread of H5N1 in vaccinated poultry. Nature 442(7104): 757.
195. Schat, K.A., and T.J. Meyers. 1991. Avian intestinal immunity. Critical Reviews in Poultry Biology 3: 19-34.
196. Schijns, V.E. 2000. Immunological concepts of vaccine adjuvant activity. Current Opinions in Immunology 12(4): 456-463.
197. Schijns, V.E. 2001. Induction and direction of immune responses by vaccine adjuvants. Critical Reviews in Immunology 21(1-3): 75-85.
198. Schijns, V.E. 2003. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine 21(9-10): 829-831.
199. Schijns, V.E., and A. Tangeras. 2005. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Developments in Biologicals 121: 127-134.
200. Schmitz, A., C. Guillemoto, I. Pierre, J. Lamande, C. Allee, D. Gomis, A. Lecu, Y. Roman, E. Bureau, T. Petit, J. Francart, and V. Jestin. 2007. Avian influenza preventive vaccination of zoo birds in France. In: Abstracts of the FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy, p. 53.
201. Schultz-Cherry, S., J.K. Dybing, N.L. Davis, C. Williamson, D.L. Suarez, R. Johnston, and M.L. Perdue. 2000. Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278: 55-59.
202. Senne, D.A., T.J. Holt, and B.L. Akey. 2005. An overview of the 2002 outbreak of low-pathogenic H7N2 avian influenza in Virginia, West Virginia and North Carolina. In: R.S. Schrijver and G. Koch (eds.). Avian Influenza. Prevention and Control, Springer: Dordrecht, 41-47.
203. Seo, K.H., P.S. Holt, L.E. Vaughn, R.K. Gast, and H.D. Stone. 2003. Detection of Salmonella enteritidis-specific immunoglobulin A antibodies in crop samples from chickens infected with Salmonella enteritidis. Poultry Science 82(1): 67-70.
204. Seo, S.H., and R.G. Webster. 2001. Crossreactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. Journal of Virology 75(6): 2516-2525.
205. Sharma, J.M. 1999. Introduction to poultry vaccines and immunity. Advances in Virus Medicine 41: 481-494.
206. Sharma, J.M., and R.L. Witter. 1983. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination. Avian Diseases 27(2): 453-463.
207. Sims, L.D. 2007. Lessons learned from Asian H5N1 outbreak control. Avian Diseases 51(1 SUPPL.): 174-181.
208. Smith, D.J., S. Bot, L. Dellamary, and A. Bot. 2003 Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Vaccine 21(21-22): 2805-2812.
209. Smith, V.W., W. Coakley, D. Maker, J.S. MacKenzie, and P.A. Lalor. 1980. The serological response of chickens to an avian influenza A virus administered by various routes. Research in Veterinary Science 29: 248-250.
210. Staats, H.F., R.J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J.R. Mcghee. 1994. Mucosal immunity to infection with implications for vaccine development. Current Opinions in Immunology 6(4): 572-583.
211. Steel, J., S.V. Burmakina, C. Thomas, E. Spackman, A. Garcia-Sastre, D.E. Swayne, and P. Palese. 2007. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine.
212. Steensels, M., S. Van Borm, B. Lambrecht, J. De Vriese, F.X. Le Gros, M. Bublot, and T. van den Berg. 2007. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Diseases 20: 325-331.
213. Stone, H., B. Mitchell, and M. Brugh. 1997. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines. Avian Diseases 41(4): 856-863.
214. Stone, H.D. 1987. Efficacy of avian influenza oilemulsion vaccines in chickens of various ages. Avian Diseases 31: 483-490.
215. Stone, H.D. 1988. Optimization of hydrophilelipophile balance for improved efficacy of Newcastle disease and avian influenza oil-emulsion vaccines. Avian Diseases 32: 68-73.
216. Stone, H.D. 1989. Efficacy of oil-emulsion vaccines prepared with pigeon paramyxovirus-1, Ulster, and La Sota Newcastle disease viruses. Avian Diseases 33(1): 157-162.
217. Stone, H.D. 1991. The preparation and efficacy of manually emulsified Newcastle disease oilemulsion vaccines. Avian Diseases 35(1): 8-16.
218. Stone, H.D. 1993. Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza. Avian Diseases 37: 399-405.
219. Stone, H.D. 1997. Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils. Avian Diseases 41(3): 591-597.
220. Stone, H.D., M. Brugh, S.R. Hopkins, H.W. Yoder, and C.W. Beard. 1978. Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens. Avian Diseases 22(4): 666-674.
221. Stone, H.D., and Z.X. Xie. 1990. Efficacy of experimental Newcastle disease water-in-oil oilemulsion vaccines formulated from squalane and squalene. Avian Diseases 34(4): 979-983.
222. Suarez, D.L. 2005. Overview of avian influenza DIVA test strategies. Biologicals 33(4): 221-226.
223. Suarez, D.L., C.W. Lee, and D.E. Swayne. 2006. Avian influenza vaccination in North America: strategies and difficulties. Developments in Biologicals 124: 117-124.
224. Suarez, D.L., and C.S. Schultz. 2000. Immunology of avian influenza virus: a review. Developmental and Comparative Immunology 24(2-3): 269-283.
225. Suarez, D.L., and S. Schultz-Cherry. 2000. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Diseases 44(4): 861-868.
226. Subbarao, K., H.L. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X.Y. Xu, X.H. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305(1): 192-200.
227. Subbarao, K., R.G. Webster, Y. Kawaoka, and B.R. Murphy. 1995. Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses? Virus Research 39: 105-118.
228. Suguitan, A.L., Jr., J. McAuliffe, K.L. Mills, H. Jin, G. Duke, B. Lu, C.J. Luke, B. Murphy, D.E. Swayne, G. Kemble, and K. Subbarao. 2006. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Medicine 3(9): e360.
229. Swayne, D.E. 2001. Avian influenza vaccine use during 2001. Proceedings of the Annual Meeting of the United States Animal Health Association 104: 469-471.
230. Swayne, D.E. 2003. Vaccines for list A poultry diseases: emphasis on avian influenza. Developments in Biologicals 114: 201-212.
231. Swayne, D.E. 2004. Application of new vaccine technologies for the control of transboundary diseases. Developments in Biologicals 119: 219-228.
232. Swayne, D.E. 2006. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Annals of the New York Academy of Sciences 1081: 174-181.
233. Swayne, D.E. 2008. Current developments in avian influenza vaccines including food safety aspects in vaccinated birds. Development in Biologicals.
234. Swayne, D.E., and B. Akey. 2005. Avian influenza control strategies in the United States of America. In: R.S. Schrijver and G. Koch (eds.). Avian Influenza. Prevention and Control. Springer: Dordrecht, pp. 113-130.
235. Swayne, D.E., G.E. Avellaneda, T.R. Mickle, N. Pritchard, J. Cruz, and M. Bublot. 2007. Improvements to the hemagglutination inhibition (HI) test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with agar gel immunodiffusion test in a differentiating infected from vaccinated animals (DIVA) strategy. Avian Diseases 51(3): 697-704.
236. Swayne, D.E., J.R. Beck, M. Garcia, and H.D. Stone. 1999. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathology 28: 245-255.
237. Swayne, D.E., J.R. Beck, and N. Kinney. 2000. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Diseases 44(1): 132-137.
238. Swayne, D.E., J.R. Beck, and T.R. Mickle. 1997. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Diseases 41(4): 910-922.
239. Swayne, D.E., J.R. Beck, M.L. Perdue, and C.W. Beard. 2001. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Diseases 45(2): 355-365.
240. Swayne, D.E., M. Garcia, J.R. Beck, N. Kinney, and D.L. Suarez. 2000. Protection against diverse highly pathogenic avian influenza viruses in chickens immunized with a recombinant fowl pox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18(11-12): 1088-1095.
241. Swayne, D.E., and D.A. Halvorson. 2003. Influenza. In: Y.M. Saif, H.J. Barnes, A.M. Fadly, J. R. Glisson, L.R. McDougald, and D.E. Swayne (eds.). Diseases of Poultry, 11th ed. Iowa State University Press: Ames, IA, pp. 135-160.
242. Swayne, D.E., C.W. Lee, and E. Spackman. 2006. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathology 35(2): 141-146.
243. Swayne, D.E., and T.R. Mickle. 1996. Protection of chickens against highly pathogenic Mexicanorigin H5N2 avian influenza virus by a recombinant fowlpox vaccine. Proceedings of the Annual Meeting of the United States Animal Health Association 100: 557-563.
244. Swayne, D.E., and H.D. Stone. 1996. Evaluation of inactivated H5 avian influenza virus and fowlpox recombinant vaccines and diagnostic test reagents: implications in avian influenza control and prevention stratagies. Proceedings of the Western Poultry Disease Conference 45: 35-38.
245. Swayne, D.E., D.L. Suarez, S. Schultz-Cherry, T.M. Tumpey, D.J. King, T. Nakaya, P. Palese, and A. Garcia-Sastra. 2003. Recombinant Paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Diseases 47: 1047-1050.
246. Sylte, M.J., B. Hubby, and D.L. Suarez. 2007. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 25(19): 3763-3772.
247. Takeda, K., T. Kaisho, and S. Akira. 2003. Tolllike receptors. Annual Review of Immunology 21: 335-376.
248. Taylor, J., R. Weinberg, Y. Kawaoka, R.G. Webster, and E. Paoletti. 1988. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6: 504-508.
249. Terregino, C., A. Toffan, M.S. Beato, R. De Nardi, A. Drago, and I. Capua. 2007. Conventional H5N9 vaccine suppresses shedding in specific-pathogen-free birds challenged with HPAI H5N1 A/chicken/Yamaguchi/7/2004. Avian Diseases 51: 495-497.
250. Thornton, D.H. 1988. Quality control of vaccines. In: D.J. Alexander (ed.). Developments in Veterinary Virology: Newcastle Disease. Kluwer Academic Publishers: Dordrecht, the Netherlands, pp. 347-365.
251. Tian, G., S. Zhang, Y. Li, Z. Bu, P. Liu, J. Zhou, C. Li, J. Shi, K. Yu, and H. Chen. 2005. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 34(1): 153-162.
252. Todd, C. 1928. Experiments on the Virus of Fowl Plague (II). British Journal of Experimental Pathology 9: 101-106.
253. Toivanen, A., P. Toivanen, J. Eskola, and O. Lassila. 1981. Ontogeny of the chicken lymphoid system. In: M.E. Rose, L.N. Payne, and B.M. Freeman (eds.). Avian Immunology. British Poultry Science, Ltd: Edinburgh, p. 45.
254. Toro, H., D.C. Tang, D.L. Suarez, M.J. Sylte, J. Pfeiffer, and K.R. Van Kampen. 2006. Protective avian influenza in ovo vaccination with nonreplicating human adenovirus vector. Vaccine 25(15): 2886-2891.
255. Tripathy, D.N., and W.M. Schnitzlein. 1991. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Diseases 35: 186-191.
256. Tumpey, T.M., D.R. Kapczynski, and D.E. Swayne. 2004. Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Diseases 48(1): 167-176.
257. Tumpey, T.M., R. Alvarez, D.E. Swayne, and D.L. Suarez. 2005. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. Journal of Clinical Microbiology 43(2): 676-683.
258. Utterback, W.W., and J.H. Schwartz. 1973. Epizootiology of velogenic viscerotropic Newcastle disease in Southern California, 1971-1973. Journal of the American Veterinary Medical Association 163(9): 1080-1088.
259. van Boven, M., J.A. van der Goot, A.R.W. Elbers, G. Koch, G. Nodelijk, M.C.M. de Jong, T.S. de Vries, A. Bouma, and J.A. Stegeman. 2005. Vaccination of poultry against avian influenza: epidemiological rules of thumb and experimental quantification of the effectiveness of vaccination. In: R.S. Schrijver and G. Koch (eds.). Avian Influenza. Prevention and Control. Springer: Dordrecht, pp. 85-92.
260. van der Goot, J.A., G. Koch, M.C.M. de Jong, and M. van Boven. 2005. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proceedings of the National Academy of Sciences U S A 102(50): 18141-18146.
261. van der Goot, J.A., M. van Boven, M.C. de Jong, and G. Koch. 2007. Effect of vaccination on transmission of HPAI H5N1: the effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks. Avian Diseases 51(1 SUPPL.): 323-324.
262. van der Lubben, I.M., J.C. Verhoef, G. Borchard, and H.E. Junginger. 2001. Chitosan for mucosal vaccination. Advanced Drug Delivery Reviews 52(2): 139-144.
263. Veits, J., D. Luschow, K. Kindermann, O. Werner, J.P. Teifke, T.C. Mettenleiter, and W. Fuchs. 2003. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. Journal of General Virology 84: 3343-3352.
264. Veits, J., D. Wiesner, W. Fuchs, B. Hoffmann, H. Granzow, E. Starick, E. Mundt, H. Schirrmeier, T. Mebatsion, T.C. Mettenleiter, and A. Romer-Oberdorfer. 2006. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proceedings of the National Academy of Sciences U S A 103(21): 8197-8202.
265. Villareal, C.L. 2006. Control and eradication strategies of avian influenza in Mexico. Developments in Biologicals 124: 125-126.
266. Villarreal-Chavez, C. 2007. AI control experiences in the Americas: a regional summary. Presented March 22, 2007, FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy.
267. Vogel, F.R. 2000. Improving vaccine performance with adjuvants. Clinical Infectious Diseases 30(Suppl. 3): S266-S270.
268. Waldman, R.H., and C.S. Henney. 1971. Cellmediated immunity and antibody responses in the respiratory tract after local and systemic immunization. Journal of Experimental Medicine 134(2): 482-494.
269. Wareing, M.D., and G.A. Tannock. 2001. Live attenuated vaccines against influenza; an historical review. Vaccine 19(25-26): 3320-3330.
270. Webster, R.G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. 1991. Efficacy of nucleoprotein and haemagglutinin antigens ex-pressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
271. Webster, R.G., P.A. Reay, and W.G. Laver. 1988. Protection against lethal influenza with neuraminidase. Virology 164: 230-237.
272. Webster, R.G., J. Taylor, J. Pearson, E. Rivera, and E. Paoletti. 1996. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant. Avian Diseases 40(2): 461-465.
273. Webster, R.G., R.J. Webby, E. Hoffmann, J. Rodenberg, M. Kumar, H. Chu, P. Seiler, S. Krauss, and T. Songserm. 2006. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351(2): 303-311.
274. Wernery, U., S. Joseph, W. Tarello, and M. Theneyan. 2006. Serological response of houbara bustards to an H5N1 vaccine. Veterinary Record 158(24): 840.
275. White, R.G. 1981. The structural organization of avian lymphoid tissues. In: M.E. Rose, L.N. Payne, and B.M. Freeman (eds.). Avian Immunology. British Poultry Science, Ltd: Edinburgh, p. 21.
276. Wight, P.A., R.B. Burns, B. Rothwell, and G.M. Mackenzie. 1971. The Harderian gland of the domestic fowl. I. Histology, with reference to the genesis of plasma cells and Russell bodies. Journal of Anatomy 110(Pt 2): 307-315.
277. Wood, J.M., Y. Kawaoka, L.A. Newberry, E. Bordwell, and R.G. Webster. 1985. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/chicken/Pennsylvania/1370/83 infection. Avian Diseases 29: 867-872.
278. Xie, Z.X., and H.D. Stone. 1990. Immune response to oil-emulsion vaccines with single or mixed antigens of Newcastle disease, avian influenza, and infectious bronchitis. Avian Diseases 34: 154-162.
279. Zanella, A., G. Poli, and M. Bignami. 1981. Avian influenza: approaches in the control of disease with inactivated vaccines in oil emulsion. In: R.W. Bankowski (ed.). Proceedings of the First International Symposium on Avian Influenza, April 1981, Beltsville, Maryland. Symposium on Avian Influenza, US Animal Health Association: Richmond, VA, pp. 180-183.
280. Zarzaur, B.L., and K.A. Kudsk. 2001. The mucosa-associated lymphoid tissue structure, function, and derangements. Shock 15(6): 411-420.
281. Zhao, S., M. Jin, H. Li, Y. Tan, G. Wang, R. Zhang, and H. Chen. 2005. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vac cinated and infected chickens. Avian Diseases 49(4): 488-493.
282. Zhigao, B. 2007. Field trials with chimera vaccines. Presented March 22, 2007, FAO/OIE Conference on Vaccination: A Tool for the Control of Avian Influenza, Verona, Italy.
283. Ziegler, A.F., S. Davison, H. Acland, and R.J. Eckroade. 1999. Characteristics of H7N2 (nonpathogenic) avian influenza virus infections in commercial layers, in Pennsylvania, 1997-98. Avian Diseases 43(1): 142-149.